No evidence was found for regulated ATP release from erythrocytes other than by cell lysis with all stimuli tested: mechanical, hypoxia, cAMP.
Introduction
Matching oxygen supply with demand requires specific mechanism(s) to increase blood flow in response to reduced tissue oxygen level. In addition to serving as major oxygen carriers, red blood cells (RBCs) have been proposed to function as oxygen sensors which respond to local tissue hypoxia with controlled ATP release 1 . Subsequent activation of vascular endothelial P2Y purinergic receptors stimulates the release of nitric oxide and other mediators of vasodilation, leading to vessel calibre alteration and enhanced blood flow [2] [3] [4] . In vitro studies have shown that shear stress and mechanical deformation are major stimuli of RBC ATP release, which is also induced by hypoxia [5] [6] [7] [8] . Elevated ATP levels have been found in vivo in venous effluent from exercising forearm muscle 1, 9 and further augmented by exercise performed in hypoxia 2, 10 .
Moreover, it has been demonstrated that only when the vessels were perfused with RBCs did venous effluent ATP level increase and the vessels dilate in response to low extraluminal O 2 2 .
All these results implicated RBCs in sensing low extraluminal O 2 and contributing to ATPdependent local blood flow regulation. It has been hypothesized that shear stress-and hypoxiainduced ATP release involves activation of the cAMP signaling pathway, opening up ATP conducting channels 11 . Consistent with this hypothesis, ATP release has also been observed in response to other stimuli that elevate cAMP, such as agonists of prostacyclin 12, 13 , or β -adrenergic receptors 14 (for review see 4 ). Other stimulators of ATP release from RBCs include hypotonic shock 15 and elevated temperature 16 .
Since mature mammalian RBCs are devoid of intracellular organelles, the only plausible pathways for such release appear to be limited to nonvesicular mechanisms, such as ATPconducting channels 17 . Pannexin-1 18 , voltage dependent anion channels (VDAC) and cystic fibrosis transmembrane conductance regulator (CFTR) have been implicated in conductive ATP release 13, 19 . However, hemolysis also is an important source of extracellular ATP, and intravascular hemolysis occurs in vivo as a consequence of hypoxia and mechanical trauma to RBCs [20] [21] [22] . Some degree of hemolysis is unavoidable during in vitro studies. Although it has been considered to be a potential factor contributing to stimulated ATP release in most previous investigations, its actual involvement has not yet been investigated systematically, e.g., by paired measurement of free hemoglobin and ATP in each and every sample.
In the present study, we began by evaluating different experimental approaches to evaluate stimulated ATP release from RBCs and quantify hemolysis, to determine their limitations and
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Materials and methods
Preparation and handling of erythrocytes. Human blood was collected from hemochromatosis patients undergoing phlebotomy treatment. After obtaining informed verbal consent with institutional ethic committee approval in accordance with the Declaration of Helsinki, blood was drawn by venipuncture, anti-coagulated with citrate phosphate dextrose solution, and stored at 4°C. While most experiments were performed with fresh or 1-2-day-old blood samples, qualitatively similar results were obtained with cells which had been stored for up to 14 days. All samples were centrifuged (500×g, 10 min, 4 ºC) prior to the experimental procedure. Blood plasma and buffy coat were removed by aspiration and erythrocytes were washed 3 times with physiological salt solution (PSS) containing (in mM) 140. 2 26 .
Exposure of erythrocytes to low oxygen conditions. RBC samples (in 6-well or 12-well plate format) were placed in an airtight flow-through box with a continuously-injected gas mixture containing 0% O 2 , 5% CO 2 , balanced with N 2 . After 30 min of equilibration with gentle mixing on the 3D rotator platform, hemoglobin oxygen saturation, measured by blood gas analyzer (Radiometer ABL800 Flex, London, Ont., Canada), was within the 40%-80% range, compared to 97%-99% in the controls. Statistical analysis. Statistical significance was assessed by non-parametric Mann-Whitney Utest (STATISTICA 10 software, StatSoft, Tulsa, OK, USA). Differences were considered to be significant at p<0.05. All data were expressed as mean±standard error of the mean (SE).
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Results
Hypotonic shock-induced ATP release. Figure 1A depicts an experimental example where RBC suspension samples were exposed for 5 min to isotonic PSS or 25%, 30% or 37% hypotonic PSS (i.e. containing 140.5, 105.38, 98.35 or 88.52 mM NaCl respectively). Extracellular ATP measured in supernatants increased significantly with rising hypotonicity. However, elevated hemolysis was also noted with RBCs exposed to hypotonic solutions, as revealed by hemoglobin absorbance measurement of the same supernatant samples ( Figure 1B, C) . By plotting released ATP against the number of lysed cells found in supernatant samples, we determined that released ATP (black circles) increases with the number of hemolyzed cells, and this dependence is well fitted by a linear relationship (correlation coefficient R=0.988, Figure 1D ). Such linear dependence strongly suggests that hemolysis contributes, at least in part, to hypotonic shockinduced ATP release. To verify the extent of this contribution, Figure 1 Figure 1E , where examples of similar hypotonic shock experiments performed with 3 different blood batches are presented. In all such experiments (n=8), despite up to ~10-fold variability of intracellular ATP concentration, we observed a tight, linear relationship between hemolysis level and released ATP (p<0.0001). As might be expected for release mechanisms involving cell lysis, the pannexin channel inhibitor carbenoxolone (CBX) showed no effect on hypotonic shock-induced ATP release ( Figure 1F ).
This is illustrated in
The above experiments revealed that, besides hemolysis, there was no evidence of additional ATP release that could be attributed to other mechanisms triggered by hypotonic stress. To further confirm this observation, we performed luminescence ATP imaging, as described in 27, 28 .
RBCs were deposited on poly-lysine-coated glass coverslips and bathed in LL containing PSS (see Supplemental Data: Methods). IR-DIC and luminescence images were captured simultaneously for the duration of the experiment. Figure 2A shows that all regions displaying ATP release perfectly matched sites where cells had lysed, demonstrating that ATP release occurred exclusively from lysed cells, and was not detected from cells that remained intact. The Pharmacological stimulation. Forskolin, a potent adenylate cyclase activator, was reported in several previous studies, to stimulate ATP release from RBCs. In an attempt to replicate these experiments, we tested the effect of forskolin on ATP release and found that adding small aliquot of concentrated forskolin stock solution in DMSO directly to erythrocyte suspensions markedly increased extracellular ATP ( Figure 4A ). It also illustrates that ATP responses were indistinguishable from those evoked by an equivalent volume of DMSO alone, indicating that even when final DMSO concentration (~0.27%) was harmless, some cells, presumably those in close proximity to the pipette tip, might have been exposed to high solvent levels causing their lysis. Indeed, Figure 4B reports that DMSO-evoked elevation of extracellular ATP closely followed extracellular hemoglobin. When the same amount of DMSO was pre-diluted 10-fold in PSS and then added to the cells, no increase in hemolysis or ATP release was seen. A similar result was obtained with forskolin, when its DMSO stock solution was pre-diluted 10-fold in PSS before addition to RBC suspension: neither extracellular ATP nor hemoglobin showed any increment, the latter remaining below 0.05%, as in control supernatant samples.
In subsequent experiments, only pre-diluted stock solutions containing DMSO <10% in PSS were tested to avoid hemolysis when adding dissolved agents directly to cell suspensions. With this approach, in our hands, neither forskolin alone nor forskolin in combination with papaverine and isoproterenol had any significant effect on ATP release (Figure 4C experiments but, in each case, they were significantly higher in hypoxia-treated samples than in the controls. Moreover, a tight linear relationship was observed between the 2 variables, demonstrating that hemolysis was the main mechanism responsible for ATP release in these experiments ( Figure 5B ).
Discussion
In this study, we attempted to identify cell-regulated ATP release pathway(s) in human erythrocytes. By paired measurements of ATP and free hemoglobin in each and every sample of RBC supernatants, we found that basal and stimulated ATP levels always correlated tightly with extracellular hemoglobin, a marker of cell lysis. Unexpectedly, this was seen with all stimuli tested, strongly indicating that, for each stimulus, the only source of extracellular ATP was cell lysis. In the case of hypotonic shock and cAMP/forskolin stimulation, we confirmed our observations more directly by simultaneous luminescence ATP imaging and IR-DIC imaging of substrate-attached RBCs. These experiments identified single ATP-releasing cells and revealed Basal hemolysis levels in our experiments varied between different blood donors and were elevated after prolonged blood storage. Typically between 0.01% and 0.05%, they were somewhat augmented in stimulated RBC samples subjected to shear stress, hypoxia, or hypotonic shock, but remained ≤ 0.1%. Such hemolysis values are similar to or below those reported by other investigators 5, 12, 13 . In several studies, hemolysis was stated to have contributed negligibly to stimulated ATP release, while samples with heightened hemolysis were simply excluded from the analysis. In other investigations, released ATP was corrected by subtracting average ATP attributable to hemolysis. The latter was often found to be not different or comparable in stimulated and control RBC samples. To the best of our knowledge, in most previous studies, hemolysis was not systematically measured or analyzed, i.e., in all individual samples for which ATP content was reported. As a result, its contribution to ATP release might have been underestimated or, in some cases, entirely overlooked.
In the present investigation, we tested several stimuli, including hypotonic shock, previously demonstrated to induce regulated RBC ATP release. Although not exactly a physiological stimulus, hypotonic shock is often considered as a surrogate of mechanical stimulation 30, 31 , and ATP release can be extrapolated to responses evoked by mechanical perturbations. We noted heightened hemolysis at ~25% hypotonicity, which increased with augmented hypo-osmotic shock and strongly correlated with extracellular ATP, as expected for lytic ATP release mechanism. Apart from hemolysis, non-lytic mechanism(s) may contribute to ATP release from intact erythrocytes. This would be seen as a "surplus" of released ATP above the hemolysis "background". However, ATP found in lysates of known cell density (e.g., 1,000 cell/µl) was almost exactly as that actually released by the same number of cells when they lysed during hypotonic shock. Furthermore, despite different intracellular ATP concentrations and the resulting variability of ATP release observed with various blood batches ( Figure 1E ), it always increased linearly with rising hemolysis level, demonstrating that there was no "surplus" ATP above the hemolysis "background" in all such experiments. Since hemoglobin is a major protein constituent of the RBC cytoplasm, its leakage eventually leads to cell collapse. Interestingly, after ATP release cell collapse/lysis occurred with average delay that was ~2.7-fold longer than ATP release duration (compare Figure 2 Bb and Cb). Slower hemoglobin release might be An interesting finding in our study was the effect of DMSO on ATP release. Because of its amphiphilic properties and high polarity, DMSO is widely employed as a solvent, easily permeating biological membranes and facilitating drug transport 32, 33 . However, in high concentrations, DMSO imposes osmotic stress and is toxic to cells, affecting water flow through membranes and other cell functions via incompletely understood mechanisms 34 . When added to RBC suspensions, DMSO readily diffuses into cells, resulting in cell swelling or eventual rupture (Supplemental Figure 3 and Supplemental Movie 5). We noticed a strong effect of DMSO on ATP release, when concentrated stocks of test compounds, dissolved in DMSO, were added directly to RBC suspensions. Even if the final DMSO concentration in a given volume of RBC suspension is harmless, some cells may undergo lysis, presumably exposed to the highest solvent concentration, in close proximity to the pipette tip 33, 35 . To exclude a direct effect of DMSO on cell lysis, we tested pre-diluted stocks of compounds containing <10% DMSO. In our hands, forskolin-and other cAMP-agonists did not stimulate ATP release when precautions were taken to avoid DMSO-induced osmotic stress and cell lysis. Interestingly, in several previous studies cAMP agonists (forskolin 10 µM, and IBMX 100 µM) were included in "stop" solution designed to prevent ATP release and hydrolysis in human blood samples, consistent with lack of cAMPstimulated ATP release in these investigations 16, 36 .
Recently, Mairbäurl et al., (2013) 37 addressed the role of hemolysis in shear stress-and hypoxiainduced ATP release in more detail in their in vitro study. They noted that, in shear stress experiments under normoxia, up to 50% of ATP release was due to hemolysis. Its contribution, however, decreased to <5% when RBCs were exposed to shear stress and hypoxia at the same time. Although precise correlations between hemolysis and ATP levels were not investigated, most ATP release observed in the hypoxia experiments was attributed to a cell-regulated mechanism. This was not confirmed in our study: we saw that shear stress or hypoxia alone could induce dose-dependent elevation of both extracellular ATP and free hemoglobin in cell supernatants, with strong, positive correlations between the two variables. Interestingly, hypoxia was shown to decrease deformability of RBCs and increase susceptibility to cell damage 22, 38 .
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The results presented here contradict much previously published experimental data on ATPrelease mechanism(s) in RBCs. Owing to the absence of intracellular organelles, mature mammalian RBCs were considered as the ultimate example of cell system where ATP release occurs exclusively via conductive pathways. Several channels were implicated in ATP release, including CFTR, VDAC and pannexins based on observed stimulation of ATP release e.g., by cAMP agonists, or its inhibition by various compounds, such as DIDS, flufenamic acid, glibenclamide, CBX or probenicid. All these compounds have a wide spectrum of effects, blocking other channels, transporters or processes besides putative ATP channels [39] [40] [41] [42] . Some inhibitors may directly interfere with the bioluminescence reaction used to measure ATP. For example, the stretch-activated ion channel blocker gadolinium (at 10 µM) and the anion channel blocker NPPB (at >250 µM) were found to inhibit LL bioluminescence 31, 43 . Certain inhibitors, including CBX and glibenclamide, were found to deplete cellular ATP by interfering with cell metabolism in other cell types 39, 40 . The effects of test compounds, or their solvents, on cell membrane stiffness/fragility, resulting in altered susceptibility to hemolysis, may also contribute to apparent ATP release modulation under specific experimental conditions 44 
